Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Pediatric Radiology
Published in: Pediatric Radiology 4/2019

01-04-2019 | Premedication | Minisymposium: Quality and safety

Practical administration of intravenous contrast media in children: screening, prophylaxis, administration and treatment of adverse reactions

Authors: Ezekiel Maloney, Ramesh S. Iyer, Grace S. Phillips, Shina Menon, John J. Lee, Michael J. Callahan

Published in: Pediatric Radiology | Issue 4/2019

Login to get access

Abstract

Administration of intravenous contrast media to children is a routine practice at many clinical imaging centers, that can involve special considerations. In this paper, we provide practical information to facilitate optimal performance and oversight of this task. We provide targeted screening questions that can help to identify high-risk pediatric patients for both iodine-based and gadolinium-based intravenous contrast media administration. These include children at risk for allergic-like reactions, thyroid dysfunction, contrast-induced nephropathy, and nephrogenic systemic fibrosis. We make recommendations for addressing “yes” responses to screening questions using risk stratification schema that are specific to children. We also present criteria for selecting children for premedication prior to intravenous contrast administration, and suggest pediatric regimens. Additionally, we discuss practical nuances of intravenous contrast media administration to children and provide a quick-reference table of appropriate treatments with pediatric dosages for adverse contrast reactions.
Literature
1.
2.
Trout AT, Dillman JR, Ellis JH et al (2011) Patterns of intravenous contrast material use and corticosteroid premedication in children — a survey of Society of Chairs of Radiology in Children's Hospitals (SCORCH) member institutions. Pediatr Radiol 41:1272–1283CrossRefPubMed
3.
Mithal LB, Patel PS, Mithal D et al (2017) Use of gadolinium-based magnetic resonance imaging contrast agents and awareness of brain gadolinium deposition among pediatric providers in North America. Pediatr Radiol 47:657–664CrossRefPubMed
4.
Tramer MR, von Elm E, Loubeyre P, Hauser C (2006) Pharmacological prevention of serious anaphylactic reactions due to iodinated contrast media: systematic review. BMJ 333:675CrossRefPubMedPubMedCentral
5.
Schwartz GJ, Work DF (2009) Measurement and estimation of GFR in children and adolescents. Clin J Am Soc Nephrol 4:1832–1843CrossRefPubMed
6.
Schwartz GJ, Furth SL (2007) Glomerular filtration rate measurement and estimation in chronic kidney disease. Pediatr Nephrol 22:1839–1848CrossRefPubMed
7.
8.
9.
Zappitelli M, Parikh CR, Akcan-Arikan A et al (2008) Ascertainment and epidemiology of acute kidney injury varies with definition interpretation. Clin J Am Soc Nephrol 3:948–954CrossRefPubMedPubMedCentral
10.
Colantonio DA, Kyriakopoulou L, Chan MK et al (2012) Closing the gaps in pediatric laboratory reference intervals: a CALIPER database of 40 biochemical markers in a healthy and multiethnic population of children. Clin Chem 58:854–868CrossRefPubMed
11.
Callahan MJ, Poznauskis L, Zurakowski D, Taylor GA (2009) Nonionic iodinated intravenous contrast material-related reactions: incidence in large urban children's hospital — retrospective analysis of data in 12,494 patients. Radiology 250:674–681CrossRefPubMed
12.
Dillman JR, Strouse PJ, Ellis JH et al (2007) Incidence and severity of acute allergic-like reactions to i.v. nonionic iodinated contrast material in children. AJR Am J Roentgenol 188:1643–1647CrossRefPubMed
13.
Dillman JR, Ellis JH, Cohan RH et al (2007) Frequency and severity of acute allergic-like reactions to gadolinium-containing i.v. contrast media in children and adults. AJR Am J Roentgenol 189:1533–1538CrossRefPubMed
14.
Behzadi AH, Zhao Y, Farooq Z, Prince MR (2018) Immediate allergic reactions to gadolinium-based contrast agents: a systematic review and meta-analysis. Radiology 286:471–482CrossRefPubMed
15.
Forbes-Amrhein MM, Dillman JR, Trout AT et al (2018) Frequency and severity of acute allergic-like reactions to intravenously administered gadolinium-based contrast media in children. Invest Radiol 53:313–318CrossRefPubMed
16.
17.
Morcos SK, Thomsen HS (2001) Adverse reactions to iodinated contrast media. Eur Radiol 11:1267–1275CrossRefPubMed
18.
Brockow K, Christiansen C, Kanny G et al (2005) Management of hypersensitivity reactions to iodinated contrast media. Allergy 60:150–158CrossRefPubMed
19.
Canter LM (2005) Anaphylactoid reactions to radiocontrast media. Allergy Asthma Proc 26:199–203PubMed
20.
Hagan JB (2004) Anaphylactoid and adverse reactions to radiocontrast agents. Immunol Allergy Clin North Am 24:507–519CrossRefPubMed
21.
Davenport MS, Cohan RH, Caoili EM, Ellis JH (2009) Repeat contrast medium reactions in premedicated patients: frequency and severity. Radiology 253:372–379CrossRefPubMed
22.
Meth MJ, Maibach HI (2006) Current understanding of contrast media reactions and implications for clinical management. Drug Saf 29:133–141CrossRefPubMed
23.
Beckett KR, Moriarity AK, Langer JM (2015) Safe use of contrast media: what the radiologist needs to know. Radiographics 35:1738–1750CrossRefPubMed
24.
Morcos SK (2005) Review article: acute serious and fatal reactions to contrast media: our current understanding. Br J Radiol 78:686–693CrossRefPubMed
25.
Namasivayam S, Kalra MK, Torres WE, Small WC (2006) Adverse reactions to intravenous iodinated contrast media: an update. Curr Probl Diagn Radiol 35:164–169CrossRefPubMed
26.
Iyer RS, Schopp JG, Swanson JO et al (2013) Safety essentials: acute reactions to iodinated contrast media. Can Assoc Radiol J 64:193–199CrossRefPubMed
27.
Bettmann MA, Heeren T, Greenfield A, Goudey C (1997) Adverse events with radiographic contrast agents: results of the SCVIR Contrast Agent Registry. Radiology 203:611–620CrossRefPubMed
28.
Callahan MJ, Servaes S, Lee EY et al (2014) Practice patterns for the use of iodinated i.v. contrast media for pediatric CT studies: a survey of the Society for Pediatric Radiology. AJR Am J Roentgenol 202:872–879CrossRefPubMed
29.
Tsushima Y, Ishiguchi T, Murakami T et al (2016) Safe use of iodinated and gadolinium-based contrast media in current practice in Japan: a questionnaire survey. Jpn J Radiol 34:130–139CrossRefPubMed
30.
Beaty AD, Lieberman PL, Slavin RG (2008) Seafood allergy and radiocontrast media: are physicians propagating a myth? Am J Med 121:158.e1–158.e4CrossRef
31.
Boehm I (2008) Seafood allergy and radiocontrast media: are physicians propagating a myth? Am J Med 121:e19CrossRefPubMed
32.
Kim MH, Lee SY, Lee SE et al (2014) Anaphylaxis to iodinated contrast media: clinical characteristics related with development of anaphylactic shock. PloS One 9:e100154CrossRefPubMedPubMedCentral
33.
Morales-Cabeza C, Roa-Medellin D, Torrado I et al (2017) Immediate reactions to iodinated contrast media. Ann Allergy Asthma Immunol 119:553–557CrossRefPubMed
34.
Tomas M, Fuentes Aparicio V, Zapatero Remon L et al (2012) Skin reactions to gadolinium-based contrast media. J Investig Allergol Clin Immunol 22:292–293PubMed
35.
Moreno Escobosa MC, Cruz Granados S (2018) Paramagnetic contrast media: hypersensitivity and cross-reactivity. J Investig Allergol Clin Immunol 28:60–62CrossRefPubMed
36.
37.
Rhee CM, Bhan I, Alexander EK, Brunelli SM (2012) Association between iodinated contrast media exposure and incident hyperthyroidism and hypothyroidism. Arch Intern Med 172:153–159CrossRefPubMed
38.
Institute of Medicine (US) Panel on Micronutrients (2001) Dietary reference intakes for vitamin A, vitamin K, arsenic, boron, chromium, copper, iodine, iron, manganese, molybdenum, nickel, silicon, vanadium, and zinc: 8 iodine. National Academies Press, Washington, DC
39.
Pramyothin P, Leung AM, Pearce EN et al (2011) Clinical problem-solving. A hidden solution. N Engl J Med 365:2123–2127CrossRefPubMed
40.
Wolff J, Chaikoff IL (1948) Plasma inorganic iodide as a homeostatic regulator of thyroid function. J Biol Chem 174:555–564PubMed
41.
Lee SY, Rhee CM, Leung AM et al (2015) A review: radiographic iodinated contrast media-induced thyroid dysfunction. J Clin Endocrinol Metab 100:376–383CrossRefPubMed
42.
43.
Parazzini C, Baldoli C, Scotti G, Triulzi F (2002) Terminal zones of myelination: MR evaluation of children aged 20-40 months. AJNR Am J Neuroradiol 23:1669–1673PubMedPubMedCentral
44.
Rovet JF (2014) The role of thyroid hormones for brain development and cognitive function. Endocr Dev 26:26–43CrossRefPubMed
45.
Lazarus J, Brown RS, Daumerie C et al (2014) 2014 European thyroid association guidelines for the management of subclinical hypothyroidism in pregnancy and in children. Eur Thyroid J 3:76–94CrossRefPubMedPubMedCentral
46.
Padovani RP, Kasamatsu TS, Nakabashi CC et al (2012) One month is sufficient for urinary iodine to return to its baseline value after the use of water-soluble iodinated contrast agents in post-thyroidectomy patients requiring radioiodine therapy. Thyroid 22:926–930CrossRefPubMedPubMedCentral
47.
48.
Brough R, Jones C (2006) Iatrogenic iodine as a cause of hypothyroidism in infants with end-stage renal failure. Pediatr Nephrol 21:400–402CrossRefPubMed
49.
Knudsen N, Christiansen E, Brandt-Christensen M et al (2000) Age- and sex-adjusted iodine/creatinine ratio. A new standard in epidemiological surveys? Evaluation of three different estimates of iodine excretion based on casual urine samples and comparison to 24 h values. Eur J Clin Nutr 54:361–363CrossRefPubMed
50.
Francis GL, Waguespack SG, Bauer AJ et al (2015) Management guidelines for children with thyroid nodules and differentiated thyroid cancer. Thyroid 25:716–759CrossRefPubMedPubMedCentral
51.
Cantais A, Hammouda Z, Mory O et al (2016) Incidence of contrast-induced acute kidney injury in a pediatric setting: a cohort study. Pediatr Nephrol 31:1355–1362CrossRefPubMed
52.
Zo'o M, Hoermann M, Balassy C et al (2011) Renal safety in pediatric imaging: randomized, double-blind phase IV clinical trial of iobitridol 300 versus iodixanol 270 in multidetector CT. Pediatr Radiol 41:1393–1400CrossRefPubMedPubMedCentral
53.
Mehta RL, Kellum JA, Shah SV et al (2007) Acute Kidney Injury Network: report of an initiative to improve outcomes in acute kidney injury. Crit Care 11:R31CrossRefPubMedPubMedCentral
54.
Bruce RJ, Djamali A, Shinki K et al (2009) Background fluctuation of kidney function versus contrast-induced nephrotoxicity. AJR Am J Roentgenol 192:711–718CrossRefPubMed
55.
Newhouse JH, Kho D, Rao QA, Starren J (2008) Frequency of serum creatinine changes in the absence of iodinated contrast material: implications for studies of contrast nephrotoxicity. AJR Am J Roentgenol 191:376–382CrossRefPubMed
56.
McDonald RJ, McDonald JS, Carter RE et al (2014) Intravenous contrast material exposure is not an independent risk factor for dialysis or mortality. Radiology 273:714–725CrossRefPubMed
57.
Davenport MS, Khalatbari S, Cohan RH, Ellis JH (2013) Contrast medium-induced nephrotoxicity risk assessment in adult inpatients: a comparison of serum creatinine level- and estimated glomerular filtration rate-based screening methods. Radiology 269:92–100CrossRefPubMedPubMedCentral
58.
McDonald JS, McDonald RJ, Carter RE et al (2014) Risk of intravenous contrast material-mediated acute kidney injury: a propensity score-matched study stratified by baseline-estimated glomerular filtration rate. Radiology 271:65–73CrossRefPubMed
59.
McDonald RJ, McDonald JS, Bida JP et al (2013) Intravenous contrast material-induced nephropathy: causal or coincident phenomenon? Radiology 267:106–118CrossRefPubMed
60.
Davenport MS, Khalatbari S, Cohan RH et al (2013) Contrast material-induced nephrotoxicity and intravenous low-osmolality iodinated contrast material: risk stratification by using estimated glomerular filtration rate. Radiology 268:719–728CrossRefPubMed
61.
Bedoya MA, White AM, Edgar JC et al (2017) Effect of intravenous administration of contrast media on serum creatinine levels in neonates. Radiology 284:530–540CrossRefPubMed
62.
Schneider G, Schurholz H, Kirchin MA et al (2013) Safety and adverse effects during 24 hours after contrast-enhanced MRI with gadobenate dimeglumine (MultiHance) in children. Pediatr Radiol 43:202–211CrossRefPubMed
63.
Marti-Bonmati L, Vega T, Benito C et al (2000) Safety and efficacy of Omniscan (gadodiamide injection) at 0.1 mmol/kg for MRI in infants younger than 6 months of age: phase III open multicenter study. Invest Radiol 35:141–147CrossRefPubMed
64.
Schneider J, Khemani R, Grushkin C, Bart R (2010) Serum creatinine as stratified in the RIFLE score for acute kidney injury is associated with mortality and length of stay for children in the pediatric intensive care unit. Crit Care Med 38:933–939CrossRefPubMed
65.
Akcan-Arikan A, Zappitelli M, Loftis LL et al (2007) Modified RIFLE criteria in critically ill children with acute kidney injury. Kidney Int 71:1028–1035CrossRefPubMed
66.
Mammen C, Al Abbas A, Skippen P et al (2012) Long-term risk of CKD in children surviving episodes of acute kidney injury in the intensive care unit: a prospective cohort study. Am J Kidney Dis 59:523–530CrossRefPubMed
67.
Alkandari O, Eddington KA, Hyder A et al (2011) Acute kidney injury is an independent risk factor for pediatric intensive care unit mortality, longer length of stay and prolonged mechanical ventilation in critically ill children: a two-center retrospective cohort study. Crit Care 15:R146CrossRefPubMedPubMedCentral
68.
Greenberg JH, Coca S, Parikh CR (2014) Long-term risk of chronic kidney disease and mortality in children after acute kidney injury: a systematic review. BMC Nephrol 15:184CrossRefPubMedPubMedCentral
69.
Choyke PL, Cady J, DePollar SL, Austin H (1998) Determination of serum creatinine prior to iodinated contrast media: is it necessary in all patients? Tech Urol 4:65–69PubMed
70.
Tippins RB, Torres WE, Baumgartner BR, Baumgarten DA (2000) Are screening serum creatinine levels necessary prior to outpatient CT examinations? Radiology 216:481–484CrossRefPubMed
71.
72.
73.
74.
Coresh J, Byrd-Holt D, Astor BC et al (2005) Chronic kidney disease awareness, prevalence, and trends among U.S. adults, 1999 to 2000. J Am Soc Nephrol 16:180–188CrossRefPubMed
75.
Pottel H, Hoste L, Delanaye P (2015) Abnormal glomerular filtration rate in children, adolescents and young adults starts below 75 mL/min/1.73 m(2). Pediatr Nephrol 30:821–828CrossRefPubMed
76.
77.
Younathan CM, Kaude JV, Cook MD et al (1994) Dialysis is not indicated immediately after administration of nonionic contrast agents in patients with end-stage renal disease treated by maintenance dialysis. AJR Am J Roentgenol 163:969–971CrossRefPubMed
78.
Group TS, Zeitler P, Hirst K et al (2012) A clinical trial to maintain glycemic control in youth with type 2 diabetes. N Engl J Med 366:2247–2256CrossRef
79.
American Diabetes Association (2018) Children and adolescents: standards of medical care in diabetes -- 2018. Diabetes Care 41:S126–S136CrossRef
80.
81.
82.
Fraum TJ, Ludwig DR, Bashir MR, Fowler KJ (2017) Gadolinium-based contrast agents: a comprehensive risk assessment. J Magn Reson Imaging 46:338–353CrossRefPubMed
83.
Spinazzi A (2014) MRI contrast agents and nephrogenic systemic fibrosis. In: Schellock FG, Crues JV, Karacozoff AM (eds) MRI bioeffects, safety, and patient management, 4th edn. Biomedical Research Publishing Group, Los Angeles, pp 256–281
84.
Nardone B, Saddleton E, Laumann AE et al (2014) Pediatric nephrogenic systemic fibrosis is rarely reported: a RADAR report. Pediatr Radiol 44:173–180CrossRefPubMed
85.
Weller A, Barber JL, Olsen OE (2014) Gadolinium and nephrogenic systemic fibrosis: an update. Pediatr Nephrol 29:1927–1937CrossRefPubMed
86.
Penfield JG (2008) Nephrogenic systemic fibrosis and the use of gadolinium-based contrast agents. Pediatr Nephrol 23:2121–2129CrossRefPubMed
87.
Somashekar DK, Davenport MS, Cohan RH et al (2013) Effect of intravenous low-osmolality iodinated contrast media on patients with myasthenia gravis. Radiology 267:727–734CrossRefPubMed
88.
Mervak BM, Davenport MS, Ellis JH, Cohan RH (2015) Rates of breakthrough reactions in inpatients at high risk receiving premedication before contrast-enhanced CT. AJR Am J Roentgenol 205:77–84CrossRefPubMed
89.
Jingu A, Fukuda J, Taketomi-Takahashi A, Tsushima Y (2014) Breakthrough reactions of iodinated and gadolinium contrast media after oral steroid premedication protocol. BMC Med Imaging 14:34CrossRefPubMedPubMedCentral
90.
Kim YS, Choi YH, Cho YJ et al (2018) Incidence of breakthrough reaction in patients with prior acute allergic-like reactions to iodinated contrast media according to the administration route. Korean J Radiol 19:352–357CrossRefPubMedPubMedCentral
91.
Mervak BM, Cohan RH, Ellis JH et al (2017) Intravenous corticosteroid premedication administered 5 hours before CT compared with a traditional 13-hour oral regimen. Radiology 285:425–433CrossRefPubMed
92.
Lee SY, Yang MS, Choi YH et al (2017) Stratified premedication strategy for the prevention of contrast media hypersensitivity in high-risk patients. Ann Allergy Asthma Immunol 118:339–344CrossRefPubMed
93.
Davenport MS, Mervak BM, Ellis JH et al (2016) Indirect cost and harm attributable to oral 13-hour inpatient corticosteroid prophylaxis before contrast-enhanced CT. Radiology 279:492–501CrossRefPubMed
94.
Wang CL, Cohan RH, Ellis JH et al (2008) Frequency, outcome, and appropriateness of treatment of nonionic iodinated contrast media reactions. AJR Am J Roentgenol 191:409–415CrossRefPubMed
95.
Aljebab F, Choonara I, Conroy S (2016) Systematic review of the toxicity of short-course oral corticosteroids in children. Arch Dis Child 101:365–370CrossRefPubMed
96.
Dunsky EH, Zweiman B, Fischler E, Levy DA (1979) Early effects of corticosteroids on basophils, leukocyte histamine, and tissue histamine. J Allergy Clin Immunol 63:426–432CrossRefPubMed
97.
Lasser EC (1988) Pretreatment with corticosteroids to prevent reactions to i.v. contrast material: overview and implications. AJR Am J Roentgenol 150:257–259CrossRefPubMed
98.
O'Malley RB, Cohan RH, Ellis JH et al (2011) A survey on the use of premedication prior to iodinated and gadolinium-based contrast material administration. J Am Coll Radiol 8:345–354CrossRefPubMed
99.
Ring J, Rothenberger KH, Clauss W (1985) Prevention of anaphylactoid reactions after radiographic contrast media infusion by combined histamine H1- and H2-receptor antagonists: results of a prospective controlled trial. Int Arch Allergy Appl Immunol 78:9–14CrossRefPubMed
100.
Small P, Satin R, Palayew MJ, Hyams B (1982) Prophylactic antihistamines in the management of radiographic contrast reactions. Clin Allergy 12:289–294CrossRefPubMed
101.
Smith DC, Taylor FC, McKinney JM (1995) Dimenhydrinate pretreatment in patients receiving intra-arterial ioxaglate: effect on nausea and vomiting. Can Assoc Radiol J 46:449–453PubMed
102.
Wicke L, Seidl G, Kotscher E et al (1975) Side effects of roentgen contrast media injections with and without antihistaminics. Wien Med Wochenschr 725:698–701PubMed
103.
Greenberger PA, Halwig JM, Patterson R, Wallemark CB (1986) Emergency administration of radiocontrast media in high-risk patients. J Allergy Clin Immunol 77:630–634CrossRefPubMed
104.
Park HJ, Park JW, Yang MS et al (2017) Re-exposure to low osmolar iodinated contrast media in patients with prior moderate-to-severe hypersensitivity reactions: a multicentre retrospective cohort study. Eur Radiol 27:2886–2893CrossRefPubMed
105.
Abe S, Fukuda H, Tobe K, Ibukuro K (2016) Protective effect against repeat adverse reactions to iodinated contrast medium: premedication vs. changing the contrast medium. Eur Radiol 26:2148–2154PubMed
106.
Bashir MR, Bhatti L, Marin D, Nelson RC (2015) Emerging applications for ferumoxytol as a contrast agent in MRI. J Magn Reson Imaging 41:884–898CrossRefPubMed
107.
108.
109.
Barrett BJ, Parfrey PS (2006) Clinical practice. Preventing nephropathy induced by contrast medium. N Engl J Med 354:379–386CrossRefPubMed
110.
Brar SS, Aharonian V, Mansukhani P et al (2014) Haemodynamic-guided fluid administration for the prevention of contrast-induced acute kidney injury: the POSEIDON randomised controlled trial. Lancet 383:1814–1823CrossRefPubMed
111.
Merten GJ, Burgess WP, Gray LV et al (2004) Prevention of contrast-induced nephropathy with sodium bicarbonate: a randomized controlled trial. JAMA 291:2328–2334CrossRefPubMed
112.
Navaneethan SD, Singh S, Appasamy S et al (2009) Sodium bicarbonate therapy for prevention of contrast-induced nephropathy: a systematic review and meta-analysis. Am J Kidney Dis 53:617–627CrossRefPubMed
113.
Taylor AJ, Hotchkiss D, Morse RW, McCabe J (1998) PREPARED: preparation for angiography in renal dysfunction: a randomized trial of inpatient vs. outpatient hydration protocols for cardiac catheterization in mild-to-moderate renal dysfunction. Chest 114:1570–1574CrossRefPubMed
114.
Weisbord SD, Palevsky PM (2008) Prevention of contrast-induced nephropathy with volume expansion. Clin J Am Soc Nephrol 3:273–280CrossRefPubMed
115.
Zoungas S, Ninomiya T, Huxley R et al (2009) Systematic review: sodium bicarbonate treatment regimens for the prevention of contrast-induced nephropathy. Ann Intern Med 151:631–638CrossRefPubMed
116.
Yunos NM, Bellomo R, Hegarty C et al (2012) Association between a chloride-liberal vs. chloride-restrictive intravenous fluid administration strategy and kidney injury in critically ill adults. JAMA 308:1566–1572CrossRefPubMed
117.
Yunos NM, Bellomo R, Taylor DM et al (2017) Renal effects of an emergency department chloride-restrictive intravenous fluid strategy in patients admitted to hospital for more than 48 hours. Emerg Med Australas 29:643–649CrossRefPubMed
118.
Nijssen EC, Rennenberg RJ, Nelemans PJ et al (2017) Prophylactic hydration to protect renal function from intravascular iodinated contrast material in patients at high risk of contrast-induced nephropathy (AMACING): a prospective, randomised, phase 3, controlled, open-label, non-inferiority trial. Lancet 389:1312–1322CrossRefPubMed
119.
ACT Investigators (2011) Acetylcysteine for prevention of renal outcomes in patients undergoing coronary and peripheral vascular angiography: main results from the randomized Acetylcysteine for Contrast-induced nephropathy Trial (ACT). Circulation 124:1250–1259CrossRef
120.
Cohen MD, Herman E, Herron D et al (1992) Comparison of intravenous contrast agents for CT studies in children. Acta Radiol 33:592–595CrossRefPubMed
121.
Lieberman PL, Seigle RL (1999) Reactions to radiocontrast material. Anaphylactoid events in radiology. Clin Rev Allergy Immunol 17:469–496CrossRefPubMed
122.
123.
Dunnick NR, Cohan RH (1994) Cost, corticosteroids, and contrast media. AJR Am J Roentgenol 162:527–529CrossRefPubMed
124.
Cohan RH, Dunnick NR (1987) Intravascular contrast media: adverse reactions. AJR Am J Roentgenol 149:665–670CrossRefPubMed
125.
Bush WH, Swanson DP (1991) Acute reactions to intravascular contrast media: types, risk factors, recognition. and specific treatment. AJR Am J Roentgenol 157:1153–1161CrossRefPubMed
126.
Lee BY, Ok JJ, Abdelaziz Elsayed AA et al (2012) Preparative fasting for contrast-enhanced CT: reconsideration. Radiology 263:444–450CrossRefPubMed
127.
Glutig K, Bhargava R, Hahn G et al (2016) Safety of gadobutrol in more than 1,000 pediatric patients: subanalysis of the GARDIAN study, a global multicenter prospective non-interventional study. Pediatr Radiol 46:1317–1323CrossRefPubMedPubMedCentral
128.
Scala M, Koob M, de Buttet S et al (2018) A pharmacokinetics, efficacy, and safety study of gadoterate meglumine in pediatric subjects aged younger than 2 years. Invest Radiol 53:70–79CrossRefPubMedPubMedCentral
129.
Bhargava R, Hahn G, Hirsch W et al (2013) Contrast-enhanced magnetic resonance imaging in pediatric patients: review and recommendations for current practice. Magn Reson Insights 6:95–111PubMedPubMedCentral
130.
Lozano LA, Marn C, Goodman LR (2012) Power injectable peripherally inserted central venous catheter lines frequently flip after power injection of contrast. J Comput Assist Tomogr 36:427–430CrossRefPubMed
131.
132.
Kaste SC, Young CW (1996) Safe use of power injectors with central and peripheral venous access devices for pediatric CT. Pediatr Radiol 26:499–501CrossRefPubMed
133.
Donnelly LF, Dickerson J, Racadio JM (2007) Is hand injection of central venous catheters for contrast-enhanced CT safe in children? AJR Am J Roentgenol 189:1530–1532CrossRefPubMed
134.
Boyce JA, Assa'ad A, Burks AW et al (2010) Guidelines for the diagnosis and management of food allergy in the United States: summary of the NIAID-sponsored expert panel report. J Allergy Clin Immunol 126:1105–1118CrossRefPubMedPubMedCentral
135.
Campbell RL, Li JT, Nicklas RA et al (2014) Emergency department diagnosis and treatment of anaphylaxis: a practice parameter. Ann Allergy Asthma Immunol 113:599–608CrossRefPubMed
136.
Brown JC, Tuuri RE, Akhter S et al (2016) Lacerations and embedded needles caused by epinephrine autoinjector use in children. Ann Emerg Med 67:307–315CrossRefPubMed
137.
Amaral JG, Traubici J, BenDavid G et al (2006) Safety of power injector use in children as measured by incidence of extravasation. AJR Am J Roentgenol 187:580–583CrossRefPubMed
138.
Cohan RH, Ellis JH, Garner WL (1996) Extravasation of radiographic contrast material: recognition, prevention. and treatment. Radiology 200:593–604CrossRefPubMed
139.
Sum W, Ridley LJ (2006) Recognition and management of contrast media extravasation. Australas Radiol 50:549–552CrossRefPubMed
140.
Wang CL, Cohan RH, Ellis JH et al (2007) Frequency, management, and outcome of extravasation of nonionic iodinated contrast medium in 69,657 intravenous injections. Radiology 243:80–87CrossRefPubMed
141.
Sbitany H, Koltz PF, Mays C et al (2010) CT contrast extravasation in the upper extremity: strategies for management. Int J Surg 8:384–386CrossRefPubMed
Metadata
Title
Practical administration of intravenous contrast media in children: screening, prophylaxis, administration and treatment of adverse reactions
Authors
Ezekiel Maloney
Ramesh S. Iyer
Grace S. Phillips
Shina Menon
John J. Lee
Michael J. Callahan
Publication date
01-04-2019
Publisher
Springer Berlin Heidelberg
Keyword
Premedication
Published in
Pediatric Radiology / Issue 4/2019
Print ISSN: 0301-0449
Electronic ISSN: 1432-1998
DOI
https://doi.org/10.1007/s00247-018-4306-6

Other articles of this Issue 4/2019

Pediatric Radiology 4/2019 Go to the issue

Minisymposium: Quality and safety

Pediatric CT radiation exposure: where we were, and where we are now

Original Article

Morel-Lavellée lesions: MRI characteristics in the pediatric patient

Minisymposium: Quality and safety

Clinical decision support: the role of ACR Appropriateness Criteria

Hermes

Hermes

Review

Review of paraneoplastic syndromes in children

Minisymposium: Quality and safety

Practical considerations for establishing and maintaining a magnetic resonance imaging safety program in a pediatric practice